- current CEO was a CEO of NASDAQ company before - current CFO was a CFO for a NASDAQ company as well - Dr. Shu ran Chiron's China division, now runs CBPC - closed deal with Japan's largest Pharma company - strong ties with China's CDC - has US GAAP audits
more I research the more im impressed with the background of the people in this deal. This is just under the radar, but at these prices and volume this is about to hit a bunch of radar screens IMO.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.